Pluribus Labs’s Assurant AIZ Stock Holding History

Pluribus Labs’s Portfolio AIZ Stock Details AIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,079	Closed	-$324K	–	56
2021 Q4	$324K	Buy	+2,079	New	+$330K	0.34%	120

Other funds holding AIZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Pluribus Labs's AIZ Position: Q1 2022 in Review

Pluribus Labs sold out of Assurant (AIZ) in Q1 2022, closing a stake of 2,079 shares — an estimated $324K sold.

Pluribus Labs first reported a position in AIZ in Q4 2021 and held it in 1 quarter. The position peaked at $324K in Q4 2021. 427 funds tracked by Wall St. Rank hold AIZ as of Q1 2022.

Pluribus Labs reported no remaining Assurant position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 2,079 Assurant shares in Q1 2022, an estimated $324K.
Pluribus Labs first reported a position in Assurant in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Assurant position peaked at $324K in Q4 2021.
427 funds tracked by Wall St. Rank held Assurant as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.